Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.7 |